Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MS
Lusutrombopag is a second oral thrombopoietin (TPO) receptor agonist that selectively acts on human TPO receptors. In the study, UPLC-MS/MS was used to establish a selective and sensitive method to determine lusutrombopag with poziotinib as IS (internal standard) in rat plasma. Samples were prepared...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | International Journal of Analytical Chemistry |
| Online Access: | http://dx.doi.org/10.1155/2020/7290470 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850220678258622464 |
|---|---|
| author | Bo Wang Feifei Chen Quan Zhou Yunfang Zhou Deru Meng Peiwu Geng Ailian Hua Weiping Ji Changxiong Wang Shuanghu Wang Liming Hu |
| author_facet | Bo Wang Feifei Chen Quan Zhou Yunfang Zhou Deru Meng Peiwu Geng Ailian Hua Weiping Ji Changxiong Wang Shuanghu Wang Liming Hu |
| author_sort | Bo Wang |
| collection | DOAJ |
| description | Lusutrombopag is a second oral thrombopoietin (TPO) receptor agonist that selectively acts on human TPO receptors. In the study, UPLC-MS/MS was used to establish a selective and sensitive method to determine lusutrombopag with poziotinib as IS (internal standard) in rat plasma. Samples were prepared by precipitating protein with acetonitrile as a precipitant. Separation of lusutrombopag and poziotinib was performed on a CORTECS UPLC C18 column (2.1 ∗ 50 mm, 1.6 μm). The mobile phase (acetonitrile and water containing 0.1% formic acid) with gradient elution was set at a flow rate of 0.4 ml/min. The mass spectrometric measurement was conducted under positive ion mode using multiple reaction monitoring (MRM) of m/z 592.97 ⟶ 491.02 for lusutrombopag and m/z for poziotinib (IS) 492.06 ⟶ 354.55. The linear calibration curve of the concentration range was 2–2000 ng/ml for lusutrombopag, with a lower limit of quantification (LLOQ) of 2 ng/ml. RSD of interday and intraday precision were both no more than 9.66% with the accuracy ranging from 105.82% to 108.27%. The extraction recovery of lusutrombopag was between 82.15% and 90.34%. The developed and validated method was perfectly used in the pharmacokinetic study of lusutrombopag after oral administration in rats. |
| format | Article |
| id | doaj-art-75de963c83524cb1857a5b4a53ccc036 |
| institution | OA Journals |
| issn | 1687-8760 1687-8779 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Analytical Chemistry |
| spelling | doaj-art-75de963c83524cb1857a5b4a53ccc0362025-08-20T02:06:58ZengWileyInternational Journal of Analytical Chemistry1687-87601687-87792020-01-01202010.1155/2020/72904707290470Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MSBo Wang0Feifei Chen1Quan Zhou2Yunfang Zhou3Deru Meng4Peiwu Geng5Ailian Hua6Weiping Ji7Changxiong Wang8Shuanghu Wang9Liming Hu10Department of Orthopaedics, The Sixth Affiliated Hospital of Wenzhou Medical University, The People’s Hospital of Lishui, Lishui 323000, Zhejiang, ChinaThe Laboratory of Clinical Pharmacy, The Sixth Affiliated Hospital of Wenzhou Medical University, The People’s Hospital of Lishui, Lishui 323000, Zhejiang, ChinaThe Laboratory of Clinical Pharmacy, The Sixth Affiliated Hospital of Wenzhou Medical University, The People’s Hospital of Lishui, Lishui 323000, Zhejiang, ChinaThe Laboratory of Clinical Pharmacy, The Sixth Affiliated Hospital of Wenzhou Medical University, The People’s Hospital of Lishui, Lishui 323000, Zhejiang, ChinaThe Laboratory of Clinical Pharmacy, The Sixth Affiliated Hospital of Wenzhou Medical University, The People’s Hospital of Lishui, Lishui 323000, Zhejiang, ChinaThe Laboratory of Clinical Pharmacy, The Sixth Affiliated Hospital of Wenzhou Medical University, The People’s Hospital of Lishui, Lishui 323000, Zhejiang, ChinaThe Laboratory of Clinical Pharmacy, The Sixth Affiliated Hospital of Wenzhou Medical University, The People’s Hospital of Lishui, Lishui 323000, Zhejiang, ChinaDepartment of Orthopaedics, The Sixth Affiliated Hospital of Wenzhou Medical University, The People’s Hospital of Lishui, Lishui 323000, Zhejiang, ChinaThe Laboratory of Clinical Pharmacy, The Sixth Affiliated Hospital of Wenzhou Medical University, The People’s Hospital of Lishui, Lishui 323000, Zhejiang, ChinaThe Laboratory of Clinical Pharmacy, The Sixth Affiliated Hospital of Wenzhou Medical University, The People’s Hospital of Lishui, Lishui 323000, Zhejiang, ChinaDepartment of Pharmacy, The First People’s Hospital of Wenling, Wenling 317500, Zhejiang, ChinaLusutrombopag is a second oral thrombopoietin (TPO) receptor agonist that selectively acts on human TPO receptors. In the study, UPLC-MS/MS was used to establish a selective and sensitive method to determine lusutrombopag with poziotinib as IS (internal standard) in rat plasma. Samples were prepared by precipitating protein with acetonitrile as a precipitant. Separation of lusutrombopag and poziotinib was performed on a CORTECS UPLC C18 column (2.1 ∗ 50 mm, 1.6 μm). The mobile phase (acetonitrile and water containing 0.1% formic acid) with gradient elution was set at a flow rate of 0.4 ml/min. The mass spectrometric measurement was conducted under positive ion mode using multiple reaction monitoring (MRM) of m/z 592.97 ⟶ 491.02 for lusutrombopag and m/z for poziotinib (IS) 492.06 ⟶ 354.55. The linear calibration curve of the concentration range was 2–2000 ng/ml for lusutrombopag, with a lower limit of quantification (LLOQ) of 2 ng/ml. RSD of interday and intraday precision were both no more than 9.66% with the accuracy ranging from 105.82% to 108.27%. The extraction recovery of lusutrombopag was between 82.15% and 90.34%. The developed and validated method was perfectly used in the pharmacokinetic study of lusutrombopag after oral administration in rats.http://dx.doi.org/10.1155/2020/7290470 |
| spellingShingle | Bo Wang Feifei Chen Quan Zhou Yunfang Zhou Deru Meng Peiwu Geng Ailian Hua Weiping Ji Changxiong Wang Shuanghu Wang Liming Hu Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MS International Journal of Analytical Chemistry |
| title | Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MS |
| title_full | Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MS |
| title_fullStr | Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MS |
| title_full_unstemmed | Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MS |
| title_short | Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MS |
| title_sort | pharmacokinetics of lusutrombopag a novel thrombopoietin receptor agonist in rats by uplc ms ms |
| url | http://dx.doi.org/10.1155/2020/7290470 |
| work_keys_str_mv | AT bowang pharmacokineticsoflusutrombopaganovelthrombopoietinreceptoragonistinratsbyuplcmsms AT feifeichen pharmacokineticsoflusutrombopaganovelthrombopoietinreceptoragonistinratsbyuplcmsms AT quanzhou pharmacokineticsoflusutrombopaganovelthrombopoietinreceptoragonistinratsbyuplcmsms AT yunfangzhou pharmacokineticsoflusutrombopaganovelthrombopoietinreceptoragonistinratsbyuplcmsms AT derumeng pharmacokineticsoflusutrombopaganovelthrombopoietinreceptoragonistinratsbyuplcmsms AT peiwugeng pharmacokineticsoflusutrombopaganovelthrombopoietinreceptoragonistinratsbyuplcmsms AT ailianhua pharmacokineticsoflusutrombopaganovelthrombopoietinreceptoragonistinratsbyuplcmsms AT weipingji pharmacokineticsoflusutrombopaganovelthrombopoietinreceptoragonistinratsbyuplcmsms AT changxiongwang pharmacokineticsoflusutrombopaganovelthrombopoietinreceptoragonistinratsbyuplcmsms AT shuanghuwang pharmacokineticsoflusutrombopaganovelthrombopoietinreceptoragonistinratsbyuplcmsms AT liminghu pharmacokineticsoflusutrombopaganovelthrombopoietinreceptoragonistinratsbyuplcmsms |